1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

  • All
    • Last 3 Years

Publishers

About 5500 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2024

  • $ 3000
  • May 2020
  • 195 pages

Global Immuno-Oncology Market, By Major Indications ##. ## Head & Neck Cancer ##. ## Lung Cancer ##. ## Melanoma ##. ## Lymphoma ##. ## Leukemia ##. ## Others ##.

  • Lymphoma
  • Oncology
  • Therapy
  • World
  • Market Size

Lymphoma Treatment Drugs Markets in China

  • $ 4000
  • October 2019
  • 206 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Shenzhen Main Luck Pharmaceuticals Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Global Mantle Cell Lymphoma Therapeutics Market 2019-2023

  • $ 2500
  • July 2019
  • 131 pages

Global Mantle Cell Lymphoma Therapeutics Market: About this market Mantle cell lymphoma therapeutics are available in combination therapy and monotherapy.

  • Lymphoma
  • Therapy
  • World
  • Demand
  • Forecast

Lymphoma Treatment Drugs Companies in China

  • $ 1800
  • October 2019
  • 71 pages

Developing Lymphoma Treatment Drugs is very important in curing Lymphoma illness.

  • Lymphoma
  • Pharmaceutical
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Pfizer Inc.

Lymphoma Treatment Drugs Industry Forecasts - China Focus

  • $ 1800
  • October 2019
  • 84 pages

LYMPHOMA TREATMENT DRUGS PRODUCTION AND I.

  • Pharmaceutical
  • China
  • Demand
  • Trade
  • Jiangsu HengRui Medicine Co., Ltd.

Global Anaplastic Lymphoma Kinase (ALK) Inhibitors Market 2020-2024

  • $ 2500
  • June 2020
  • 120 pages

Our anaplastic lymphoma kinase (ALK) inhibitors market covers the following areas: • Anaplastic lymphoma kinase (ALK) inhibitors market sizing • Anaplastic lymphoma kinase (ALK) inhibitors market forecast • Anaplastic lymphoma kinase (ALK) inhibitors market

  • Lymphoma
  • Therapy
  • Forecast

Global Follicular Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • October 2018
  • 105 pages

Hoffmann-La Roche • Gilead • Merck About Follicular Lymphoma Follicular lymphoma is a subtype of B-cell non-Hodgkin lymphoma (NHL).

  • Lymphoma
  • Therapy
  • World
  • Market Size

The 2021-2026 World Outlook for Lymphoma Therapeutics

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for lymphoma therapeutics across more than ## countries.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Demand

Global Burkitt Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • September 2018
  • 109 pages

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Spectrum Pharmaceuticals About Burkitt Lymphoma Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022

  • $ 2500
  • October 2018
  • 110 pages

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Pfizer • Spectrum Pharmaceuticals About Diffuse Large B-Cell Lymphoma DLBCL is a cancer of B-lymphocytes.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Lymphoma Drugs Market 2017-2021

  • $ 2500
  • June 2017
  • 86 pages

The aim of lymphoma treatment is to get rid of the lymphoma cells.

  • Cancer
  • Lymphoma
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Market Spotlight: Mantle Cell Lymphoma

  • $ 1318
  • November 2019
  • 47 pages

Key Takeaways The analyst estimates that in 2017, there were approximately ##, ## incident cases of mantle cell lymphoma (MCL) worldwide, and forecasts that number to increase to ##, ## incident cases by 2026.

  • Drug Development
  • Lymphoma
  • World

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030

  • $ 2850
  • May 2020
  • 100 pages

Anaplastic lymphoma kinase Non Small Cell Lung Cancer (ALK-NSCLC) - Epidemiology Forecast to 2030 ##.

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • Germany

Anaplastic lymphoma kinase Non-Small Cell Lung Cancer (ALK-NSCLC)-Market Insights, Epidemiology and Market Forecast to 2030

  • $ 4750
  • May 2020
  • 200 pages

Anaplastic lymphoma kinase Non-Small Cell Lung Cancer Drug Chapters Drug chapter segment of the Anaplastic lymphoma kinase Non-Small Cell Lung Cancer report encloses the detailed analysis of Anaplastic lymphoma kinase Non-Small Cell Lung Cancer marketed drugs and late stag

  • Cancer
  • Lung Cancer
  • Lymphoma
  • Pathology
  • United States

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026

  • $ 22000
  • January 2019
  • 510 pages

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026 CONTENTS ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET DYNAMICS ## FORECAST AND FUTURE TRENDS ## MARKET DEFINITION AND METHODOLOGY ## PRIMARY

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • $ 2400
  • March 2018
  • 280 pages

Diffuse Large B Cell Lymphoma ##. ## Introduction ##. ## Classification of Diffuse Large B Cell Lymphoma ##.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Market Size

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence

  • $ 22000
  • October 2018
  • 475 pages

NHL: Diffuse Large B Cell Lymphoma Forecast and Market Analysis to 2034, Pharma Intelligence Table of Contents (Forecast, Treatment, Epidemiology Datapacks included) ## FORECAST: DIFFUSE LARGE B-CELL LYMPHOMA (Published on ## October 2018) ## OVERVIEW ## RECENT FORECAST UPDATES

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States

Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 900
  • June 2020
  • 82 pages

B-cell lymphomas can be categorized into aggressive NHL, such as diffuse large B-Cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and burkitt' s lymphoma (BL), and indolent NHL, such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma

  • Autoimmune Disease
  • Lymphoma
  • Therapy
  • World
  • AbbVie Inc.

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • $ 22000
  • April 2018
  • 229 pages

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025 TABLE OF CONTENTS Forecast, Treatment, Epidemiology Datapacks included) & nbsp; ## FORECAST: FOLLICULAR LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET OVERVIEW AND TRENDS ## METHODOLOGY

  • Cancer
  • Lymphoma
  • European Union
  • Japan
  • United States

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034

  • $ 22000
  • April 2018
  • 196 pages

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and Market Analysis to 2034 TABLE OF CONTENTS & nbsp; (Forecast, Treatment and Epidemiology Datapacks included) & nbsp; ## FORECAST: MANTLE CELL LYMPHOMA (Published on ## April 2016) ## OVERVIEW ## EXECUTIVE SUMMARY ## MARKET

  • Cancer
  • Lymphoma
  • Pathology
  • European Union
  • United States
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on